Ceryvyn Therapeutics Ltd
OPT
Rankning i aktier
#31854
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Aktiekurs
$0.00846342
Senast synkroniserad: 2026-07-27
Marknadsvärde
$11.27M
Förändring (1 dag)
0.00%
Förändring (1 år)
-99.75%
Land
AU
Handel Ceryvyn Therapeutics Ltd (OPT)
Kategori
Healthcare
Historik för aktiesplit för Ceryvyn Therapeutics Ltd (OPT)
Aktien Ceryvyn Therapeutics Ltd (symbol: OPT) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den Oct 16, 2020.
En OPT-aktie köpt före Sep 13, 2016 motsvarar nu 0.638125 OPT-aktier.
Den senaste spliten skedde den Oct 16, 2020.
En OPT-aktie köpt före Sep 13, 2016 motsvarar nu 0.638125 OPT-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2020-10-16 | 5:8 | x0.625 | x0.638125 |
| 2016-09-13 | 1021:1000 | x1.021 | x1.021 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
